House panel says China is subsidizing fentanyl production to fuel crisis in U.S.
China is fueling the fentanyl crisis in the U.S. by directly subsidizing the manufacturing of materials that are used by traffickers to make the drug outside the country, according to a report released Tuesday by a special House committee focused on countering the Chinese government.
Committee investigators said they accessed a Chinese government website that revealed tax rebates for the production of specific fentanyl precursors as well as other synthetic drugs as long as those companies sell them outside of China.
“Through its actions, as our report has revealed, the Chinese Communist Party is telling us that it wants more fentanyl entering our country,” said Rep. Mike Gallagher, the Republican chairman of the special House committee. “It wants the chaos and devastation that has resulted from the epidemic.”
In November, President Biden and Chinese President Xi Jinping announced a resumption of bilateral cooperation on counternarcotics with a focus on reducing the flow of precursor chemicals and synthetic drug trafficking. But the congressional report raises questions about whether China is following through.
The report’s findings were released Tuesday as part of a hearing examining China’s role in the fentanyl epidemic in the U.S. Most overdose deaths in the U.S. continue to be linked to fentanyl and other synthetic opioids. Inexpensive fentanyl is increasingly cut into other drugs, often without the buyers’ knowledge.
A new report blames fentanyl for more fatal overdoses in L.A. County than methamphetamine for the first time in recent years. The opioid’s victims are disproportionately Black.
The Chinese government not only subsidizes the manufacturing of precursor chemicals, but the report says it has also thwarted investigations into illicit manufacturers by warning the targets of an investigation when U.S. law enforcement has sent a formal request for assistance. Investigators said multiple current and former federal agents have described the notification of targets, leading those targets to revamp operations and make it harder to detect their activities.
Former Atty. Gen. William Barr told lawmakers in Tuesday’s hearing that it’s hard to believe that a country with the most pervasive surveillance system in the world is not fully aware of the massive drug trafficking taking place. He said the committee’s report “uncovered persuasive evidence” that China’s government is not just a bystander, but is “knee deep” in sponsoring and facilitating the export of fentanyl precursors.
Barr recommended the U.S. use its trade and economic power to seek greater enforcement from Chinese authorities. He also said victims should bring civil actions against companies and individuals involved in distributing the precursors and synthetic drugs.
“I don’t think we can count on their goodwill, as we have in the past,” Barr said.
The Chinese Embassy in Washington did not respond immediately to a request for comment.
In an effort to slow the proliferation of synthetic opioid-related deaths, California will begin offering free fentanyl-testing strips to eligible organizations across the state that ask for them, the state Department of Health Care Services announced Thursday.
Rep. Raja Krishnamoorthi, the top Democrat on the committee, said Chinese companies are also currently selling synthetic opioids on their websites, and pointed to a screenshot of one such solicitation that committee staff found just Monday night in advance of the hearing. He said such posts have to be taken down immediately.
“There are hundreds of these website posts — hundreds” Krishnamoorthi said. “This is completely unacceptable.”
The chemical companies providing fentanyl precursors often have legitimate businesses with customers around the world. The report said fentanyl precursors and other synthetic narcotics are a “side hustle” designed to maximize profits.
Businesses that deal in fentanyl precursors and narcotics on the side are particularly vulnerable to U.S sanctions. The same goes for companies such as banks, online platforms and shipping companies that enable illicit fentanyl trade.
The report calls on Congress to clarify the power of the president to sanction those involved in drug trafficking, for the U.S. to impose financial sanctions on violators and for regular reports to Congress on how often sanctions have been undertaken.
It also calls for forming a task force that would place intelligence, economic and enforcement resources under one roof. The head of the group would report directly to the attorney general and serve as a special assistant to the president on the National Security Council with authority over the opioids portfolio.
Freking writes for the Associated Press.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
